Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant
Description
During the COVID-19 pandemic, expedient vaccine production has been slowed by the shortage of safe and effective raw materials, such as adjuvants, essential components to enhance the efficacy of vaccines. Monophosphoryl lipid A (MPLA) is a potent and
